{"id":"W4400452669","doi":"10.1016/j.jtho.2024.05.270","title":"PP01.24 FURVENT: Phase 3 trial testing furmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertions (FURMO-004)","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Exon; Oncology; Chemotherapy; Internal medicine; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00136126,0.001039475,0.0009527431,0.0002929977,0.0003047478,0.001368576,0.0007297748,0.001965558,0.02452386],"category_scores_gemma":[0.001515233,0.0003683234,0.001836081,0.0002337891,0.0004168301,0.0008382449,0.0003723225,0.004338157,0.003157648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008020649,"about_ca_system_score_gemma":0.001061251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001140499,"about_ca_topic_score_gemma":0.004157393,"domain_scores_codex":[0.9996676,0.0001641675,0.00001284112,0.00005054746,0.00003244987,0.00007231136],"domain_scores_gemma":[0.999438,0.0001468329,0.0000946449,0.00003178702,0.00004197151,0.0002467817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6894982,0.01498027,0.002686474,0.002829587,0.003919901,0.0002673701,0.0001627886,0.003329101,0.02132752,0.001923651,0.09707409,0.1620012],"study_design_scores_gemma":[0.8154638,0.1452514,0.007567876,0.0002981204,0.001142984,0.0002510205,0.0000716315,0.002238408,0.00202668,0.001273144,0.02435913,0.00005586578],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8564349,0.01735044,0.00262325,0.01622119,0.004993235,0.01027012,0.04331299,0.001466805,0.04732709],"genre_scores_gemma":[0.8876188,0.007238686,0.004171201,0.0149288,0.001560273,0.008200961,0.02701759,0.0002598492,0.04900382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02452386,"threshold_uncertainty_score":0.08204049,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06063335095721781,"score_gpt":0.4938462651588927,"score_spread":0.4332129142016748,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}